The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.10
Bid: 43.10
Ask: 46.90
Change: 1.30 (2.97%)
Spread: 3.80 (8.817%)
Open: 43.10
High: 43.10
Low: 43.10
Prev. Close: 43.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

12 Aug 2019 07:00

RNS Number : 6375I
Benchmark Holdings PLC
12 August 2019
 

 

12 August 2019

 

Information within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Q3 Trading Update

 

Benchmark, the aquaculture health, nutrition and genetics business today provides the following Q3 trading update.

The Company has continued to face challenging conditions in the global shrimp and Mediterranean seabass/bream markets, as outlined in its half year results in June 2019, which has impacted sales volumes in Advanced Nutrition. Additionally, the Company is experiencing a reduced contribution from trials of certain pre-license pipeline products within Animal Health, as a result of making good progress towards satisfactorily concluding trials with fewer treatments than expected, and from delays in commencing trials in several territories.

The Company's expectations of the revenue and profit mix for the full year have also changed. The Company is actively progressing its programme of operational and structural efficiencies, including key commercial licensing deals for its non-core animal vaccines, which, if completed this financial year, are expected to substantially offset the negative variance referred to above. However, there is a risk to the delivery of these deals within the current financial year.

Notwithstanding these short-term challenges, the Board believes that the Company is well positioned in its markets and the opportunities for its existing products and those coming from its pipeline are strong. The Company continues to progress delivery of its five year strategy to drive future growth and profitability.

Enquiries

 

For further information, please contact:

Benchmark Holdings plc

Tel: 020 3915 1236

Malcolm Pye, CEO

Mark Plampin, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Freddie Naylor-Leyland

 

MHP Communications

Tel: 020 3128 8742 / 07551 170 451

Katie Hunt / Reg Hoare / Alistair de Kare-Silver benchmark@mphc.com

 

 

About Benchmark Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVFLFFKVFFBBZ
Date   Source Headline
9th Aug 20163:26 pmRNSHolding(s) in Company
5th Aug 20167:00 amRNSPlacing of 47.3 million new ordinary shares
29th Jul 20167:00 amRNSDirectorate Change
19th Jul 20167:00 amRNSNew Seabass Vaccine Commences Field Trials
12th Jul 20167:00 amRNSBreeding & Genetics Contract Win
28th Jun 20167:00 amRNSHalf-year Report
3rd Jun 20167:00 amRNSChange of Adviser
27th May 20167:00 amRNSChange of Auditor
26th May 20167:00 amRNSTrading Update and Notice of Results
22nd Apr 201610:45 amRNSHolding(s) in Company
18th Apr 20169:40 amRNSIssue of Equity
22nd Mar 20169:07 amRNSBlocklisting Interim Review
10th Mar 201610:13 amRNSResult of AGM
5th Feb 20162:51 pmRNSDirector Dealings
2nd Feb 20167:00 amRNSFinal Results
7th Jan 201611:02 amRNSHolding(s) in Company
5th Jan 201612:08 pmRNSHolding(s) in Company
4th Jan 20163:04 pmRNSHolding(s) in Company
4th Jan 20163:00 pmRNSHolding(s) in Company
4th Jan 201611:18 amRNSHolding(s) in Company
4th Jan 201610:47 amRNSHolding(s) in Company
4th Jan 201610:43 amRNSHolding(s) in Company
4th Jan 201610:40 amRNSHolding(s) in Company
4th Jan 20169:26 amRNSHolding(s) in Company
4th Jan 20169:19 amRNSHolding(s) in Company
31st Dec 20157:00 amRNSFurther admission of shares
29th Dec 201511:43 amRNSResult of General Meeting
14th Dec 201511:00 amRNSSchedule 1 - Benchmark Holdings plc
14th Dec 20157:30 amRNSRestoration - Benchmark Holdings plc
14th Dec 20157:00 amRNSPlacing and Acquisition
9th Nov 20157:00 amRNSCanine Vaccine Licensing Deal Secured
6th Nov 201511:28 amRNSResponse to Lumpfish VHS
8th Oct 20152:43 pmRNSFurther re. potential acquisition
8th Oct 201512:15 pmRNSPotential acquisition and suspension of shares
8th Oct 201512:15 pmRNSSuspension - Benchmark Holdings Plc
30th Sep 20157:00 amRNSSalmoBreed breakthrough
30th Sep 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSBlock Admission Application
27th Jul 20157:00 amRNSAcquisition
13th Jul 20153:40 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
6th May 20155:46 pmRNSHolding(s) in Company
30th Apr 201512:44 pmRNSHolding(s) in Company
29th Apr 20157:00 amRNSTrading Statement
23rd Apr 201512:34 pmRNSHolding(s) in Company
17th Mar 201512:25 pmRNSHolding(s) in Company
10th Mar 20151:13 pmRNSDirector Share Options
5th Mar 201510:43 amRNSResult of AGM
26th Feb 20152:39 pmRNSHolding(s) in Company
16th Feb 20151:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.